

Treat to Target in Rheumatic Diseases: Rationale and Results
In stock$39.99
13 viewing now
Format*
1
SKU:GC-743977853
Orders arrive in about 7-11 business days.
Returns accepted for 30 days after purchase.

Treat to Target in Rheumatic Diseases: Rationale and Results
$39.99
Guest edited by Dr. Daniel Aletaha, this issue of Rheumatic Disease Clinics will cover “Treat to Target in Rheumatic Diseases” with a focus on rationale and results. This issue is one of four selected each year by our series Consulting Editor, Dr. Michael Weisman. Articles explore diseases, including, but not limited to: History, Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthropathies, Systemic lupus erythematosus, PMR and GCA, Inflammatory Myopathies (PM/DM), Gout, and Subclinical Targets.\nTreat to Target in Rheumatic Diseases: Rationale and Results and published by Elsevier. ISBNs for Treat to Target in Rheumatic Diseases: Rationale and Results are 9780323678971, 0323678971 and the print ISBNs are 9780323678964, 0323678963.
Product Details
TypeBest Seller zetlly pro
SKUGC-743977853
TagsBest Seller zetlly pro




